BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17642944)

  • 1. Disability prevention and management in leprosy: a field experience.
    Ganapati R; Pai VV; Kingsley S
    Indian J Dermatol Venereol Leprol; 2003; 69(6):369-74. PubMed ID: 17642944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Government health workers as implementers of prevention of disability measures: an assessment of a prevention of disability project in selected counties of Guizhou Province, Peoples' Republic of China.
    Li J; Mu H; Ke W; Bao X; Wang Y; Shen LM; Cross H
    Lepr Rev; 2008 Sep; 79(3):295-302. PubMed ID: 19009978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on the effect of patient and community education in prevention of disability programme.
    Ethiraj T; Antony P; Krishnamurthy P; Reddy NB
    Indian J Lepr; 1995; 67(4):435-45. PubMed ID: 8849920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing socio-economic factors in relation to stigmatization, impairment status, and selection for socio-economic rehabilitation: a 1-year cohort of new leprosy cases in north Bangladesh.
    Withington SG; Joha S; Baird D; Brink M; Brink J
    Lepr Rev; 2003 Jun; 74(2):120-32. PubMed ID: 12862253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey of leprosy disabilities in patients treated with multiple drug therapy in Ivory Coast].
    Tiendrebéogo A; Djakeaux DS; Assé H; Eba ME; Sica A
    Acta Leprol; 1997; 10(3):151-8. PubMed ID: 9281294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based needs assessment of leprosy patients in Chamrajanagar district, Karnataka, India.
    Gautham MS; Dayananda M; Gopinath D; Shivraj NS; Riyaz B; Pruthvish S
    Lepr Rev; 2011 Sep; 82(3):286-95. PubMed ID: 22125937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the contribution of the Swedish International Development Authority (SIDA) to leprosy control in India based on the implementation of multiple drug therapy (MDT) 1981-1993.
    Peat M; Brolin L; Ganapati R; McDougall AC; Revankar CR; Watson JW
    Indian J Lepr; 1995; 67(4):447-65. PubMed ID: 8849921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of leprosy impairments and disabilities among patients treated by MDT in Burkina Faso.
    Tiendrebeogo A; Toure I; Zerbo PJ
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):15-25. PubMed ID: 8627109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences from a collaborative project on the prevention of disability in leprosy patients in Shandong Province, the People's Republic of China.
    Chen S; Zhang L; Wang Z; Zhou J; Liu Y; Mao C
    Lepr Rev; 2001 Sep; 72(3):330-6. PubMed ID: 11715279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving compliance of leprosy patients with disabilities for disability care and prevention of disability services.
    Joshi ; Revankar CR
    Indian J Lepr; 1998; 70 Suppl():39S-45S. PubMed ID: 10992866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring impairment caused by leprosy: inter-tester reliability of the WHO disability grading system.
    Nienhuis WA; van Brakel WH; Butlin CR; van der Werf TS
    Lepr Rev; 2004 Sep; 75(3):221-32. PubMed ID: 15508899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of disability in leprosy.
    Manglani PR
    J Indian Med Assoc; 2004 Dec; 102(12):680-3. PubMed ID: 15871351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disabilities observed in new cases of leprosy diagnosed in the Bamako district (Mali) in 1994].
    Sow SO; Tiendrebeogo A; Hamed Oould B; Lienhart C; Ponnighaus JM
    Acta Leprol; 1999; 11(4):161-70. PubMed ID: 10987047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disability index of hands and feet in patients attending an urban leprosy clinic.
    Thappa DM; Kaur S; Sharma VK
    Indian J Lepr; 1990; 62(3):328-37. PubMed ID: 2262718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of disabilities and physical rehabilitation of leprosy].
    Smith WC
    Acta Leprol; 1996; 10(2):85-8. PubMed ID: 9054199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can plantar ulcers associated with leprosy be treated in the field. Results of experience in Senegal].
    Grauwin MY; Ndiaye A; Sylla PM; Gaye AB; Mane I; Cartel JL; Lepers JP
    Sante; 1998; 8(3):199-204. PubMed ID: 9690320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disability prevention in Hansen's disease: reality at a health service].
    Pedrazzani ES; Maluf SA; Pedroso M; Toyoda CY
    Hansenol Int; 1985; 10(1-2):10-22. PubMed ID: 2977126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustainable leprosy related disability care within integrated general health services: findings from Salem District, India.
    Madhavan K; Vijayakumaran P; Ramachandran L; Manickam C; Rajmohan R; Mathew J; Krishnamurthy P
    Lepr Rev; 2007 Dec; 78(4):353-61. PubMed ID: 18309709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve thickening in leprosy patients and risk of paralytic deformities: a field based study in Agra, India.
    Kumar A; Girdhar A; Girdhar BK
    Lepr Rev; 2004 Jun; 75(2):135-42. PubMed ID: 15282964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.